Prevalence of Ocular Toxoplasmosis Among People Living with HIV: a Systematic Review and Meta-analysis

Overview

Journal Future Microbiol

Specialties Infectious Diseases
Microbiology

Date 2024 Mar 20

PMID 38507297

Authors

Maria Kantzanou

Evangelos Kostares

Georgia Kostare

Fotini Boufidou

Antzela Tzanai

Michael Kostares

Athanasios Tsakris

Affiliations

Soon will be listed here.

Abstract

To determine the prevalence of ocular toxoplasmosis among people living with HIV through a systematic review and meta-analysis. A literature search was conducted, estimating pooled prevalence and performing quality assessment, outlier, influential and meta-regression analyses. Twenty-nine studies were included in the analysis, revealing that the rate of ocular toxoplasmosis among people living with HIV was 0.37% (95% CI: 0.2-0.6). Substantial heterogeneity was observed among the studies. Despite analyzing continuous variables, including year of publication, proportion of males, mean age and proportion of patients receiving antiretroviral therapy, no statistically significant associations were found. This study provides an overview of the prevalence of ocular toxoplasmosis in people living with HIV, emphasizing the need for further research to uncover factors contributing to its development.

Citing Articles

Ocular Toxoplasmosis: Advances in Biology, Clinical Manifestations, Diagnostics, and Therapy.

Miyagaki M, Zong Y, Yang M, Zhang J, Zou Y, Ohno-Matsui K Pathogens. 2024; 13(10).

PMID: 39452769 PMC: 11509995. DOI: 10.3390/pathogens13100898.

Prevalence of Leishmaniasis among Blood Donors: A Systematic Review and Meta-Analysis.

Kantzanou M, Kostares E, Kostare G, Papagiannopoulou E, Kostares M, Tsakris A Diseases. 2024; 12(7).

PMID: 39057131 PMC: 11276524. DOI: 10.3390/diseases12070160.

Seroprevalence of among HIV Positive Patients under Surveillance in Greek Infectious Disease Units: A Screening Study with Comparative Evaluation of Serological Methods.

Voyiatzaki C, Zare Chormizi A, Tsoumani M, Efstathiou A, Konstantinidis K, Chaniotis D Pathogens. 2024; 13(5).

PMID: 38787227 PMC: 11123859. DOI: 10.3390/pathogens13050375.

References

Fabiani S, Caroselli C, Menchini M, Gabbriellini G, Falcone M, Bruschi F . Ocular toxoplasmosis, an overview focusing on clinical aspects. Acta Trop. 2021; 225:106180. DOI: 10.1016/j.actatropica.2021.106180. View

Abdollahi A, Heidari-Bateni G, Zarei R, Kheirandish P, Malekmadani M, Mohraz M . Clinical spectrum of 15 patients with HIV-related ocular involvement in Tehran. Int J Ophthalmol. 2012; 3(4):331-6. PMC: 3340748. DOI: 10.3980/j.issn.2222-3959.2010.04.13. View

Wang Z, Jia R, Ge S, He T, Zhang Y, Yang Y . Ocular complications of human immunodeficiency virus infection in eastern china. Am J Ophthalmol. 2011; 153(2):363-369.e1. DOI: 10.1016/j.ajo.2011.07.018. View

Lamichhane G, Shah D, Sharma S, Chaudhary M . Ocular manifestations in HIV/AIDS cases in Nepal. Nepal J Ophthalmol. 2010; 2(1):45-50. DOI: 10.3126/nepjoph.v2i1.3704. View

E J, Wang Z, Ssekasanvu J, Munoz B, West S, Ludigo J . Visual Impairment and Eye Diseases in HIV-infected People in the Antiretroviral Therapy (ART) Era in Rakai, Uganda. Ophthalmic Epidemiol. 2020; 28(1):63-69. PMC: 7752824. DOI: 10.1080/09286586.2020.1791908. View

Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View

Luo J, Jing D, Kozak I, Huiming Z, Siying C, Yezhen Y . Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China. Ophthalmic Epidemiol. 2013; 20(3):170-5. DOI: 10.3109/09286586.2013.789530. View

Abdollahi A, Mohraz M, Rasoulinejad M, Shariati M, Kheirandish P, Abdollahi M . Retinitis due to opportunistic infections in Iranian HIV infected patients. Acta Med Iran. 2013; 51(10):711-4. View

Linzerova D, Stepanov A, Nemcansky J . Ocular Manifestations in Patients with HIV infection. Cesk Slov Oftalmol. 2019; 74(6):234-239. DOI: 10.31348/2018/6/3. View

10.

Jabs D, Van Natta M, Holbrook J, Kempen J, Meinert C, Davis M . Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology. 2007; 114(4):780-6. DOI: 10.1016/j.ophtha.2006.11.008. View

11.

Butler N, Furtado J, Winthrop K, Smith J . Ocular toxoplasmosis II: clinical features, pathology and management. Clin Exp Ophthalmol. 2012; 41(1):95-108. PMC: 4028599. DOI: 10.1111/j.1442-9071.2012.02838.x. View

12.

Bekele S, Gelaw Y, Tessema F . Ocular manifestation of HIV/AIDS and correlation with CD4+ cells count among adult HIV/AIDS patients in Jimma town, Ethiopia: a cross sectional study. BMC Ophthalmol. 2013; 13:20. PMC: 3679865. DOI: 10.1186/1471-2415-13-20. View

13.

Kalogeropoulos D, Sakkas H, Mohammed B, Vartholomatos G, Malamos K, Sreekantam S . Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches. Int Ophthalmol. 2021; 42(1):295-321. PMC: 8351587. DOI: 10.1007/s10792-021-01994-9. View

14.

Gangaputra S, Drye L, Vaidya V, Thorne J, Jabs D, Lyon A . Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 2012; 155(2):206-212.e5. PMC: 4164649. DOI: 10.1016/j.ajo.2012.07.019. View

15.

Begg C, Mazumdar M . Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50(4):1088-101. View

16.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

17.

Fernandes Felix J, Lira R, Grupenmacher A, de Assis Filho H, Cosimo A, Nascimento M . Long-term Results of Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrent Toxoplasma gondii Retinochoroiditis. Am J Ophthalmol. 2020; 213:195-202. DOI: 10.1016/j.ajo.2019.12.025. View

18.

Emina M, Odjimogho S . Ocular problems in HIV and AIDS patients in Nigeria. Optom Vis Sci. 2010; 87(12):979-84. DOI: 10.1097/OPX.0b013e3181fef198. View

19.

Accorinti M, Pirraglia M, Corradi R, Corsi C, Fabiani C, Pivetti-Pezzi P . Changing patterns of ocular manifestations in HIV seropositive patients treated with HAART. Eur J Ophthalmol. 2006; 16(5):728-32. DOI: 10.1177/112067210601600511. View

20.

Maclean H, Hall A, McCombe M, Sandland A . AIDS and the eye. A 10-year experience. Aust N Z J Ophthalmol. 1996; 24(1):61-7. DOI: 10.1111/j.1442-9071.1996.tb01553.x. View